Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreatic ductal adenocarcinoma.
Li Z, Fan X, Jiang D, Li Q, Liu C, Wang D, Li N, Li H, Chen Z, Tang H, Lou C, Xu H, Zhan C, Dong Y, Ma Z, Wang G, Zhang C, Lu H, Zheng T, Zhang Y.
Li Z, et al. Among authors: ma z.
Oncologist. 2024 Nov 4;29(11):997-e1614. doi: 10.1093/oncolo/oyae207.
Oncologist. 2024.
PMID: 39226089
Free PMC article.